Introduction
============

Autophagy ("self-eating" in greek) is a highly conserved intracellular catabolic pathway that occurs in response to different forms of stress such as starvation, hypoxia, drugs, infection, growth factor deprivation and ROS accumulation. The main function of autophagy is to provide nutrients for vital cellular functions during fasting and other stressors and selectively eliminate unwanted, potentially harmful cytosolic material, such as damaged mitochondria or protein aggregates. There are different forms of autophagy: microautophagy, chaperon-mediated autophagy, mitophagy and macroautophagy. The latter (in the following referred to as the ALP, or simply as autophagy), consists in degrading and recycling cell components by a vesicular structure called the autophagolysosome, that comes from the fusion of an autophagosome with a lysosome ([@B8]).

Autophagy-lysosomal pathway plays a pivotal role in a wide range of physiological and pathological conditions and is fundamental for the nervous system. Terminally differentiated cells that no longer divide, such as neurons, depend on basal autophagy for the proper turnover of cytoplasmic contents and for protein quality control. Consequently, ALP-deficient mice accumulate ubiquitinated protein aggregates in neurons and suffer from neurodegeneration even in the absence of other pathological triggers ([@B10]; [@B19]). Autophagy is also required for proper membrane turnover in axon terminals ([@B20]) and for neurogenesis, the production of new neurons from neural stem cells (NSCs). Here we will provide a condensed review of the current knowledge about the physiological role of basal autophagy in neurogenesis, surveying the data available in embryonic development and the few studies conducted in adults. The general role of autophagy in neurogenesis and stem cell regulation has been the subject of other reviews, to which we would like to refer the reader for more extended information ([@B6]; [@B3]). For a better understanding of the topic, we will first give a brief overview of the main autophagy players in mammalian cells and their pharmacological manipulation.

The Autophagy-Lysosomal Pathway
===============================

Autophagy-lysosomal pathway is a step-wise procedure regulated by several protein complexes: the ULK1-Atg13-FIP200-Atg101 complex, required for autophagy induction; the class III phosphatidylinositol 3-kinase (PI3K) complex (PI3K/Vsp34, Beclin1, Atg14/Atg14L, Vps15, and Ambra1), responsible for autophagosome initiation and the Atg12-Atg5-Atg16L1 and LC3-I/LC3-II complexes, fundamental for the extension and closure of the autophagosome ([@B36]) (**Figure [1](#F1){ref-type="fig"}**). We will next focus on how these proteins control ALP steps:

![The mammalian autophagy-lysosomal pathway (ALP). Under glucose starvation, AMP activated protein kinase (AMPK) promotes autophagy by directly activating uncoordinated 51-like kinase 1 (ULK1) and transcription factor EB (TFEB) translocates to the nucleus to induce the transcription of several lysosomal genes. Under nutrient sufficiency, high mammalian target of rapamycin (mTOR) activity prevents ULK1 activation and phosphorylates TFEB that remains in the cytoplasm. The ULK1 activation leads to the formation of ULK1-ATG13-FIP200-ATG101 complex, which in turn triggers the class III phosphatidylinositol 3-kinase (PI3K) complex formation. Both complexes participate in the formation of the endoplasmic reticulum cradle, from which the IM (isolation membrane) grows. Two ubiquitin-like conjugating systems are responsible for autophagosome formation: the ATG12-ATG5-ATG16L1 system and the microtubule-associated protein 1 light chain 3 (LC3) system, while ATG9 transmembrane protein collaborates in the delivery of lipids, and in the elongation and closure of the autophagosome. The ATG complex is recruited to the pre-autophagosomal membrane by Eva1a/TMEM166. Cargo recruitment is achieved thanks to a variety of receptor proteins for ubiquitinated proteins such as p62/SQSTM1, histone deacetylase 6 (HDAC6) and NBR1. Finally, the proteins LAMPs, RAB7 and HDAC6 regulate autophagosome fusion with lysosomes, and the lysosomal acidic hydrolases are responsible for degrading the autophagy cargo. Autophagy proteins whose function has been analyzed in relation to adult neurogenesis are highlighted in red (see also **Table [1](#T1){ref-type="table"}**). β-catenin and Notch1 (signaling pathway components) are degraded through autophagy during embryonic neurogenesis and are shown in green. This figure was produced using images from Servier Medical Art, licensed under a Creative Commons Attribution 3.0 Unported License. <http://smart.servier.com>.](fncel-12-00339-g001){#F1}

1.  *Autophagy induction* is tightly regulated by mTOR and AMPK, a metabolic sensor of the AMP/ATP ratio. Under nutrient deprivation, AMPK promotes autophagy through ULK1 phosphorylation at Ser317 and Ser777, whilst under nutrient sufficiency, high mTOR activity phosphorylates ULK1 at Ser757 preventing its activation ([@B16]). In addition, TFEB is normally phosphorylated by mTOR and is retained in the cytosol, but under fasting TFEB translocates to the nucleus to induce lysosomal gene expression ([@B29]), enhancing the cell's degradative capability ([@B37]). Autophagy induction can be modulated by several chemical compounds such as rapamycin, which inhibits mTOR ([@B1]) and metformin, an indirect activator of AMPK ([@B17]).

2.  *Vesicle nucleation (phagophore formation).* ULK1 activation leads to FIP200 and Atg13 phosphorylation, causing the assembly of the ULK1-Atg13-FIP200-Atg101 complex, which in turn triggers class III PI3K complex formation. The subsequent PI3-phosphate enrichment leads to formation of the endoplasmic reticulum cradle, from which an IM grows ([@B2]). The IM can be also originated from other sources (**Figure [1](#F1){ref-type="fig"}**) and forms a cup-shaped structure termed the phagophore that recruits autophagy (Atg)-related proteins ([@B7]). This step can be modulated by the class III PI3K inhibitors 3-methyladenine (3-MA) and wortmannin ([@B50]).

3.  *Vesicle elongation (autophagosome formation)* depends on two ubiquitin-like conjugating systems: Atg12-Atg5-Atg16L1 and LC3 ([@B47]). First, Atg5 binds to Atg12 in a reaction catalyzed by Atg7 and Atg10; the resulting complex is conjugated to Atg16L1 and is recruited to the pre-autophagosomal membrane by Eva1a/TMEM166 ([@B12]; [@B26]). Atg12-Atg5-Atg16L1 assists in the recruitment of LC3, which gets cleaved by Atg4 to form LC3-I that in turn is conjugated to phosphatidylethanolamine by Atg3 and Atg7, generating lipidated LC3-II that participates in phagophore membrane elongation ([@B48]).

4.  *Cargo recruitment and* *completion*. Autophagy is a highly selective process that requires a variety of receptor proteins to recruit ubiquitinated (Ub)-cargoes to the forming autophagosomes, such as p62/SQSTM1, HDAC6 ([@B22]) and NBR1 ([@B18]). P62 is a ubiquitin-binding protein that interacts with (Ub)-proteins and LC3 ([@B34]), acting as a bridge between Ub-protein aggregates/autophagosomes and as a regulator of membrane formation around the sequestered cargoes ([@B38]). HDAC6 mediates the transport of Ub-proteins along microtubules ([@B22]) and the maturation of the autophagosome ([@B34]). NBR1 also recruits Ub-protein aggregates and is degraded by autophagy depending on LC3 ([@B18]). Co-localization between aggregates and receptors like p62 or NBR1 is an indicator of selective autophagy ([@B39]). Taking together the actions of the receptors and the role of Atg9 in lipid delivery, the loading and closure of the autophagosome is achieved ([@B13]).

5.  *Autophagolysosome formation and cargo degradation* are controlled by regulators of autophagosome fusion with lysosomes, such as LAMPs, SNAREs, RAB7, HDAC6 and by lysosomal acidic hydrolases ([@B27]; [@B3]). The fusion of the mature autophagosome's outer membrane with the lysosome's one leads to the degradation of the autophagosome's inner membrane as well as its contents, generating building blocks recycled by the cell ([@B36]). This final step can be modulated by bafilomycin A1, a disruptor of autophagosome-lysosome fusion and autophagolysosome acidification ([@B25]).

In the following sections, we will review the consequences of deleting autophagy-related genes or pharmacologically blocking autophagy in embryonic and adult NSPCs.

Basal Autophagy and Neurogenesis During Development
===================================================

Today we can safely say that constitutive autophagy is required for embryonic neurogenesis. The first evidences came from work showing that autophagic proteins increase during neuronal differentiation of fetal NSPCs. For instance, in NSPCs derived from the forebrain, Atg9a levels and the LC3-II/LC3-I ratio (a readout of autophagy) raised during neurogenesis ([@B28]). A simirelated genes (coding for Atg7, Beclin1, Ambra1 and LC3) was described for the OB ([@B42]). The pattern was recapitulated in cultured OB-NSPCs and occurred concomitantly with an increase in the autophagic flux ([@B42]). Similarly, Atg5, Eva1a and LC3-II proteins raised in the mouse cerebral cortex during the neurogenic period ([@B24]; [@B23]). Atg5 is highly expressed both in the cortical plate, where mature neurons reside, and in the VZ/SVZ, where it co-localizes with the NSPC marker Sox2 ([@B24]), pointing to a role of autophagy in these two cell compartments. In line with this observation, Atg5 silencing impaired cortical neuronal differentiation while increasing proliferation of VZ/SVZ NSPCs ([@B24]).

Acute silencing of Class III PI3K (Vps34) during corticogenesis by in utero electroporation also affected neurogenesis, decreasing excitatory neuron migration and axonal growth without influencing the cell cycle of NSPCs at the VZ/SVZ ([@B14]). Pharmacological disruption of autophagy with PI3K inhibitors such as Wortmaninn or 3-MA impaired neuronal differentiation of OB-NSPCs by reducing newborn neuron numbers and their maturation. Moreover, neurogenesis was decreased in OB-NSPCs from Ambra1^+/gt^ haploinsufficient mice and Atg5^−/−^ mice, but supplementation with methylpyruvate (an analog for the citric acid cycle that restores ATP availability) rescued the phenotype, indicating that OB-NSPCs require autophagy as an energy source to differentiate into neurons ([@B42]). Wortmaninn, 3-MA or bafilomycin A1 also prevented neuronal differentiation of fetal forebrain NSPC cultures ([@B28]) while overexpression of a microRNA (miR-34a) that downregulates Atg9 markedly affected neuronal differentiation and rapamycin-induced autophagy partly recovered the defect ([@B28]).

Genetic manipulations of ALP selectively in NSPCs have also yielded interesting results. In Nestin-Cre driven Eva1a conditional knockout (cKO) embryos, the number of proliferative NSPCs and TuJ1^+^BrdU^+^ newly generated neurons was greatly reduced ([@B23]). This cortical phenotype correlated with an impaired autophagy, shown by a decrease in LC3-II levels, LC3 puncta and an increase in p62 and ubiquitin. *In* *vitro* neurosphere assays revealed a defect in NSC self-renewal with no change in apoptosis, while differentiation assays uncovered a reduction both in neurogenesis and neurite length ([@B23]).

A few studies have addressed a more specific function of ALP in regulating components of signaling pathways that are key for brain development. For instance, Atg7 regulates the β-catenin-dependent branch of Wnt signaling ([@B32]). Under normal physiological conditions, β-catenin limits basal autophagy in mammalian cell lines and functions as a transcriptional co-repressor of p62, but during nutrient deprivation, β-catenin is targeted for autophagic degradation and p62 is de-repressed ([@B32]). In the embryonic brain, loss of Atg5 function decreases cortical neuronal differentiation and enhances progenitor proliferation through the stabilization of β-catenin, while Atg5 overexpression accelerates its degradation. Furthermore, the cortical phenotype observed following Atg5 silencing is fully rescued by β-catenin knockdown ([@B24]). On the other hand, it has been reported that Wnt3A decreases autophagy in mature neurons after traumatic brain injury while increasing hippocampal neurogenesis ([@B54]). In contrast, Wnt3A increases autophagy in embryonic rat hippocampal neuronal cultures through the activation of AMPK ([@B35]). This effect is β-catenin-independent, uncovering an interesting connection between Wnt signaling, neuronal metabolism and autophagy that deserves further exploration.

Another key pathway regulated by autophagy is Notch signaling. Notch1 receptor is degraded via its uptake into pre-autophagosome vesicles in an Atg16L1-dependent manner ([@B49]). Atg7 and Atg16L1 knockdown increase Notch1 levels on the plasma membrane and Notch signaling, while Beclin1 overexpression has the opposite effect. Notch1 levels are increased in Atg16L1 hypomorphs ([@B49]) and in embryonic cortical primary cultures from these mice, there is an increase in the proportion of NSCs that is reversed with Notch inhibitors. *In vivo*, the VZ/SVZ of Atg16L1 hypomorphs is larger while the cortical plate is smaller compared to wild-type mice. Thus, increased Notch1 resulting from defective autophagy impairs neuronal differentiation and expands the NSC pool ([@B49]).

Altogether, the above studies combining pharmacological approaches and autophagy-deficient mouse models demonstrate that basal autophagy is required during embryonic neurogenesis and this is partly due to the regulation of key morphogen signaling pathways. In the next section, we will review the main findings regarding the role of ALP in neurogenesis during adulthood.

Basal Autophagy and Adult Neurogenesis
======================================

Adult neurogenesis has been analyzed in animals deficient for ALP genes, with divergent results depending on which complex is targeted. Both direct (cell autonomous) effects on stem/progenitor cells and indirect (non-cell autonomous) niche-mediated effects have been identified. For the most part, the genetic strategies employed delete autophagy genes already at embryonic stages and the phenotype in the two adult neurogenic regions (the subependymal zone, SEZ, and the subgranular zone, SGZ) is analyzed in postnatal or young adults. Studies knocking out autophagy genes in stem or progenitor cells in adult mice are scarce.

Yu and co-workers first reported that insulin withdrawal induced an autophagic AMPK-dependent cell death in adult hippocampal NSPCs *in vitro* ([@B53]; [@B9]). The death correlated with the upregulation of Beclin1, LC3-II and the accumulation of autophagosomes, was partly rescued by Atg7 silencing and was enhanced with rapamycin. Later on, Chung and colleagues showed that low calpain activity underlied the switch from apoptosis to autophagic cell death ([@B5]). More recently it has been reported that oxygen-glucose deprivation (a cellular model of ischemia) also induces autophagic cell death in adult hippocampal NSPCs ([@B4]). These results suggest that blocking autophagy may be cytoprotective for insulin or oxygen-glucose deprived NSPCs.

In 2013, a seminal *in vivo* study demonstrated that FIP200-mediated autophagy is required for the maintenance and function of postnatal and adult NSPCs via the regulation of their oxidative state ([@B45]). Conditional deletion of FIP200 in radial glia during development depleted postnatal SEZ and SGZ progenitors and decreased neurogenesis. The adult neurogenic niches appeared normal at postnatal day (P) 0, but at P28, the dentate gyrus shrunk, the number of radial NSCs was reduced and astrocytes populated the SGZ, forming a dense ribbon. At this stage, the SEZ appeared thinner and was depleted of both NSPCs and PSA-NCAM^+^ neuroblasts. SEZ/SGZ proliferation became compromised and apoptosis was increased. *In vitro* neurosphere assays uncovered a reduced survival capacity of the NSCs and possibly a self-renewal defect. At P56, FIP200 deficiency raised mitochondrial mass and heterogeneity in the SEZ, increasing ROS and p53, a master regulator of cell cycle arrest and apoptosis in response to DNA damage ([@B31]). In double FIP200/p53 cKO animals, the apoptosis and proliferative defects were rescued yet differentiation was still affected, suggesting that the role of autophagy in the regulation of NSCs is uncoupled from its role in newborn neurons ([@B45]).

Neural stem cell maintenance, self-renewal and differentiation was unaffected in Atg5 and Atg16L1 cKO mice generated using the same mouse driver line employed for the FIP200 cKO (hGFAP-Cre) ([@B43]). This divergent result might be due to FIP200 functions beyond autophagy or to compensations for Atg5/Atg16L1 loss. Reinforcing the latter, p62 aggregates accumulated in the SEZ/SGZ of FIP200 cKO but not in Atg5 or Atg16L1 cKO mice; moreover, the decrease in NSPCs and proliferation was fully restored in double FIP200 and p62 cKO mice ([@B43]). At a mechanistic level, p62 aggregates reduced the activity of the superoxide dismutase SOD1, leading to oxidative stress and consequently to NSPC dysfunction. In addition, FIP200 indirectly regulated postnatal SEZ neurogenesis via microglia. Wang and colleagues demonstrated that p62 aggregates in FIP200-null NSPCs activate NF-κB and promote the production of Ccl5 and Cxcl110 chemokines, leading to microglia activation, niche infiltration and interference with NSPC differentiation ([@B44]).

The role of the Beclin1-Atg14L1-Vps34 complex in the adult SEZ has been also analyzed ([@B52]). Ambra1 and Beclin1 are expressed in SEZ Nestin^+^ NSPCs and DCX^+^ neuroblasts and high levels of GFP-LC3 are detected in the SEZ of transgenic mice. In Beclin1^+/−^ heterozygotes, proliferative cells and TuJ1^+^ neurons decrease, while active caspase-3^+^ cells increase throughout the SEZ (some co-localizing with TuJ1), evidencing a raise in apoptosis of the newly generated neurons. No *in vivo* analysis of the NSCs or intermediate progenitors using specific markers is so far available in these mice. Nevertheless, SEZ NSPC cultures from Beclin1^+/−^ mutants were defective in neurosphere formation, neuronal differentiation and showed an increase in active caspase-3. NSPCs from Ambra1^+/−^ mutants displayed a similar phenotype. Moreover, autophagy is required for radial migration of the SEZ newborn neurons upon their arrival to the OB. Lentiviral-mediated knockdown in migrating neuroblasts of a microRNA (let-7) targeting amino acid transporters \[thus involved in ALP regulation ([@B30])\], impaired migration and autophagy, whilst overexpression of Beclin1 or TFEB restored both defects ([@B33]). Together, the data indicate that basal autophagy has a pro-survival role in adult SEZ newborn neurons *in vitro* and *in vivo* and point to an additional function in the maintenance of adult NSC pools and in the final migration of the adult-born neurons within the OB.

A recent report has knocked out an autophagy gene directly in actively proliferating NSPCs of the SGZ employing a retroviral (RV) strategy ([@B51]). [@B51] injected a RV carrying an mCherry-EGFP-LC3 autophagy-sensing cassette in the dentate gyrus of young adult mice, traced the progeny of the transduced cells and found autolysosomes (mCherry^+^ puncta) in progenitors and immature neurons at all stages of development, being the most prominent accumulation in the developing processes of young neurons (\<30 days post RV injection). Next, they simultaneously tracked the autophagy flux and knocked out Atg5 in dividing NSCPs of Atg5^flox/flox^ mice, by co-injecting a second RV directing the GFP-Cre expression. As expected, Atg5-null NSPCs had less autolysosomes and their survival was markedly compromised. Atg5-null neurons experienced a transient maturation delay, with a reduction in spine density and prolonged expression of the immature marker DCX at 30 days post injection. Dendritic arborization seemed normal, although subtle defects could have been missed. This phenotype is reminiscent of the age-related maturation delay of newborn neurons ([@B41]), suggesting that a cell-autonomous failure in autophagy could partly contribute to maturation impairments during aging. Of note, the survival and the maturation timing defects were rescued in mice lacking the pro-apoptotic protein Bax ([@B51]).

More recently, [@B21] found protein aggregates in quiescent NSCs from the SEZ of young adult mice. The aggregates were stored in large lysosomes and the expression of lysosome-associated genes with TFEB motifs was increased. Detection of LAMPs and autophagy-sensing constructs indicated that quiescent NCS contained more and larger lysosomes than actively dividing NSCs. Nutrient deprivation (a pro-ALP stimulus) improved quiescent NSC activation *in vitro*, and this was blocked by bafilomycin A1, suggesting that ALP provides a burst of energy for NSC division. With age, a subset of old quiescent NSCs had defects in their lysosomes and in ALP, accumulating higher levels of protein aggregates. This was counteracted by overexpression of a constitutive active TFEB, leading to quiescent NSC activation. *In vivo* administration of rapamycin also increased the frequency of active SEZ NSPCs expressing the epidermal growth factor receptor (EGFR) in old animals, as analyzed by FACS. Although the active NSC and progenitor populations were not clearly segregated in the analysis, since they are both EGFR^+^, the finding suggests that clearing protein aggregates through ALP enhances NSC activity in the aged brain.

Future Perspectives
===================

Collectively, the above findings show a prevalent function for autophagy-related genes in embryonic neurogenesis and place autophagy at the crossroads between proteostasis anddevelopmental signaling pathways. During development, basal autophagy is mainly required for adequate neuronal differentiation and possibly to limit the expansion of the NSC population through the downregulation of the β-catenin/Wnt and Notch pathways. Commonalities and distinct features of ALP in adult *vs.* embryonic neurogenesis are also starting to emerge. The available data in the adult, summarized in **Table [1](#T1){ref-type="table"}**, point to a distinctive role of ALP in the exit of NSCs from their predominant quiescent state (a property of adult NSCs that is not shared by their embryonic counterparts) and possibly to a shared role in the differentiation/maturation of the adult and embryonic newly born neurons. Basal autophagy has also a pro-survival role in adult neurogenesis. Nevertheless, to gain further insight into the function of ALP in adult neurogenesis, future studies using tamoxifen-inducible Cre/LoxP systems are required to delete autophagy genes during adulthood, bypassing confounding embryonic and postnatal effects.

###### 

Role of autophagy in adult neurogenesis.

                                                    Cellular type/region                    Species                Effect                           Reference                                                                                                    
  --------------- --------------------------------- --------------------------------------- ---------------------- -------------------------------- ----------- -------- -------------------- ---------------------------------------------- -------- ---------- ----------------------
  Genetic model   *FIP200* (hGFAP-Cre) cKO          Neurospheres and *in vivo* (SEZ, SGZ)   *Mus musculus*         ↓ radial NSC maintenance         ↓           ↓        ↑ apoptosis          ↓ (infiltration and activation of microglia)                       [@B45], [@B44]
                  *FIP200/Trp53* (hGFAP-Cre) dcKO   *In vivo* (SEZ, SGZ)                    *Mus musculus*         rescue                           rescue                                                                                                       [@B45]
                  *Atg5* (hGFAP-Cre) cKO            Neurospheres and *in vivo* (SEZ, SGZ)   *Mus musculus*         =                                =           =        =                    =                                                                  [@B43]
                  *Atg16L1* (hGFAP-Cre) cKO         Neurospheres and *in vivo* (SEZ, SGZ)   *Mus musculus*         =                                =           =        =                    =                                                                  
                  *Beclin 1*^+/−^                   Neurospheres and *in vivo* (SEZ)        *Mus musculus*                                          ↓           ↓        † apoptosis          ↓                                                                  [@B52]
                  *Ambra1*^+/−^                     Neurospheres and *in vivo* (SEZ)        *Mus musculus*                                          ↓           ↓        † apoptosis          ↓                                                                  
                  *Let-7* (LV)                      OB                                      *Mus musculus*                                                                                                                                   ↓        ↓          [@B33]
                  *Let-7/Beclin o.e.* (LV)          OB                                      *Mus musculus*                                                                                                                                   Rescue              
                  *Let-7/TFEB o.e.* (LV)            OB                                      *Mus musculus*                                                                                                                                   Rescue              
                  *Atg5* (RV-Cre) cKO               *In vivo* (SGZ)                         *Mus musculus*                                          =           ↓                                                                                     ↓(delay)   [@B51]
                  *Atg5* (RV-Cre) cKO/*Bax*^−/−^    *In vivo* (SGZ)                         *Mus musculus*                                                      Rescue                                                                                Rescue     
                                                                                                                                                                                                                                                                 
  Treatment       Insulin withdrawal                Adherent NSPC cultures (Hippocampus)    *Rattus norvergicus*                                                         ↑ autophagic death                                                                      [@B5]; [@B9]; [@B53]
                  Insulin withdrawal, Atg7 siRNA    Adherent NSPC cultures (Hippocampus)    *Rattus norvergicus*                                                         rescue                                                                                  [@B5]
                  Oxygen-glucose deprivation        Adherent NSPC cultures (Hippocampus)    *Rattus norvergicus*                                                         ↑ autophagic death                                                                      [@B4]
                  Nutrient deprivation/TFEB         Neurospheres (SEZ, young/old animals)   *Mus musculus*         ↑ Quiescent NSC/NPC activation                                                                                                                [@B21]
                  Rapamycin                         *In vivo* (SEZ, old animals)            *Mus musculus*         ↑ Quiescent NSC/NPC activation                                                                                                                

cKO, conditional knockout; dcKO, double conditional knockout; LV, lentivirus; RV, retrovirus; o.e., overexpression.

A remaining challenge in the field is to solve whether ALP regulation is cell intrinsic/extrinsic and further refine its coupling to sequential cellular transitions of the neurogenic cascade. Moreover, little is known regarding the role of autophagy in the adult neurogenic response to external stimuli. Running increases autophagy in the brain ([@B11]) and [@B51] showed that running could not rescue the survival deficits of Atg5-null newborn neurons, but further research in this direction is warranted. Exploring in the adult the interesting connections found in the embryo between niche signals such as Notch or Wnt, NSC expansion, neuronal metabolism and autophagy will also likely expand our knowledge on the coordination between extrinsic/intrinsic mechanisms regulating neurogenesis in the mature brain.

Finally, the activation of autophagy facilitates the clearing of intracellular protein aggregates and consequently the pharmacological enhancement of ALP is viewed as a promising neuroprotective approach for a variety of neurodegenerative proteinopathies ([@B26]; [@B40]). On the other hand, autophagy is involved in the pathophysiological changes induced in the brain upon ischemic stroke ([@B55]) and possibly in NSPC cell death following radiotherapy in malignant childhood brain tumors, including high-grade gliomas ([@B46]). The potential impact of autophagy modulators on the regulation of either endogenous NSPCs/neurogenesis \[controversial in humans at this point, see [@B15] and references therein\] or the possible outcome of modulating autophagy in combination with NSPC transplantation strategies for the treatment of some of these diseases has received little attention. Autophagy may play a dual role in NSPCs and immature neurons, being adaptive and cytoprotective in basal conditions, or detrimental following exposure to ischemic environments or irradiation. On the other hand, the neurogenesis studies performed in animal models predict that inducing autophagy would favor the survival and maturation of the newly generated neurons in grafts. Thus, it is tempting to speculate that enhancing autophagy in neurodegenerative pathologies could be beneficial both for the damaged neurons and to improve the efficacy of cell replacement strategies, so we anticipate that future research in this convergence zone may yield promising results.
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